Interventional radionuclide therapy of hepatocellular carcinoma: Assessment of intratumoral retention of HPMA copolymers

Abstract

To develop new radiopharmaceuticals for the interventional radionuclide therapy of recurrent hepatocellular carcinoma, poly(HPMA)-APMA-DTPA[HPMA=N-(2-hydroxypropyl) methacrylamide; APMA=N-(3-aminopropyl)methacrylamide; DTPA=diethylenetriaminepentaacetic acid] was synthesized by free radical precipitation polymerization in acetone/dimethylsulfoxide with N,N′-azobis(isobutyronitrile) as the initiator. The copolymers were characterized with nuclear magnetic resonance(NMR) spectroscopy and gel permeation chromatography(GPC, M _n=2.2×10⁴, M _w/M _n=1.38). Subsequently, poly(HPMA)-APMA-DTPA was conjugated with ^99mTc radionuclide. Prolonged retention of poly(HPMA)-APMA-DTPA conjugate within the tumor tissues was demonstrated by single-photon emission computed tomography computed tomography(SPECT-CT) at 1, 2, 4 and 24 h following intra-tumoral injection of the conjugate to hepatocellular carcinoma xenografts in mice. DTPA-^99mTc was also synthesized and characterized for comparison. The data suggest that the poly(HPMA)-APMA-DTPA conjugates might be useful for the interventional radionuclide therapy of recurrent hepatocellular carcinoma in humans.

Keywords

Hepatocellular carcinoma / Interventional radionuclide therapy / HPMA copolymer / Radiotracer

References

[1] Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D. CA Cancer J. Clin., 2011, 61: 69.

[2] Bennet J. J., Cao D. J. Surg. Oncol., 2005, 92: 64.

[3] van de Wiele C., Defreyne L., Peeters M., Lambert B. Q. J. Nucl. Med. Mol. Imaging, 2009, 53: 317.

[4] Deleporte A., Flamen P., Hendlisz A. Expert. Opin. Pharmacother, 2010, 11: 579.

[5] Lau W. Y., Lai E. C., Leung T. W., Yu S. C. Ann. Surg., 2008, 247: 43.

[6] Partensky C., Sassolas G., Henry L., Paliard P., Maddern G. J. Arch. Surg., 2000, 135: 1298.

[7] Keng G. H., Sundram F. X., Yu S. W., Somanesan S., Premaraj J., Oon C. J., Kwok R., Htoo M. M. Ann. Acad. Med. Singapore, 2002, 31: 382.

[8] Keng G. H., Sundram F. X. Ann. Acad. Med. Singapore, 2003, 32: 518.

[9] Lambert B., van de Wiele C. Eur. J. Nucl. Med. Mol. Imaging, 2005, 32: 980.

[10] Lambert B., Bacher K., Defreyne L. Q. J. Nucl. Med. Mol. Imaging, 2009, 53: 305.

[11] Salem R., Thurston K. G., Carr B. I., Goin J. E., Geschwind J. F. J. Vasc. Interv. Radiol., 2002, 13: S223.

[12] Firusian N., Dempke W. Cancer, 1999, 85: 980.

[13] Schumacher T., Hofer S., Eichhorn K., Wasner M., Zimmerer S., Freitag P., Probst A., Gratzl O., Reubi J. C., Maecke R., Mueller-Brand J., Merlo A. Eur. J. Nucl. Med. Mol. Imaging, 2002, 29: 486.

[14] Andrews J. C., Walker S. C., Ackermann R. J., Cotton L. A. J. Nucl. Med., 1994, 35: 1637.

[15] Kim E. M., Jeong H. J., Heo Y. J., Moon H. B., Bom H. S., Kim C. G. J. Korean Med. Sci., 2004, 19: 647.

[16] Kwak C., Hong S. K., Seong S. K., Ryu J. M., Park M. S., Lee S. E. Eur. J. Nucl. Med. Mol. Imaging, 2005, 32: 1400.

[17] Mitra A., Nana A., Papadimitriouc J. C., Ghandehari H., Line B. R. Nucl. Med. Biol., 2006, 33: 43.

[18] Yuan J. C., You Y. Z., Lu X., Muzik O., Oupicky D., Peng F. Y. Mol. Imaging, 2007, 6: 10.

[19] Yang W., Mou T., Zhang X., Wang X. Appl. Radiat. Isot., 2010, 68: 105.

[20] Chaumet-Riffaud P., Martinez-Duncker I., Marty A. L., Richard C., Prigent A., Moati F., Sarda-Mantel L., Scherman D., Michel Bessodes M., Nathalie Mignet N. Bioconjug. Chem., 2010, 21: 589.

[21] Burtea G., Laurent S., Murariu O., Rattat D., Toubeau G., Verbruggen A., Vansthertem D., Vander E. L., Muller R. N. Cardiovasc. Res., 2008, 78: 148.

[22] Rihova B., Bilej M., Vetvicka V., Ulbrich K., Strohalm J., Kopecek J., Duncan R. Biomaterials, 1989, 10: 335.

[23] Seymour L. W., Ulbrich K., Strohalm J., Kopecek J., Duncan R. Biochem. Pharmacol., 1990, 39: 1125.

[24] Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. J. Control. Release, 2000, 65: 271.

[25] Duncan R., Coatsworth J. K., Burtles S. Hum. Exp. Toxicol., 1998, 17: 93.

[26] Matsumura Y., Maeda H. Cancer Res., 1986, 46: 6387.

[27] Rihova B., Bilej M., Vetvicka V., Ulbrich K., Strohalm J., Kopecek J., Duncan R. Biomaterials, 1989, 10: 335.

[28] Seymour L. W., Miyamoto Y., Maeda H., Brereton M., Strohalm J., Ulbrich K., Duncan R. Eur. J. Cancer, 1995, 31: 766.

[29] Chen F., Dong D., Fu Y., Zheng Y., Liu S., Chang M., Jing X. Chem. Res. Chinese universites, 2012, 28(4): 656.